Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction.Open heart · 2021
   Trial
2. Evaluation of a Wrist-Worn Device for ECG-Based Detection of Acute Myocardial Infarction.IEEE journal of translational engineering in health and medicine · 2026
   Article
3. Artificial intelligence in atherosclerotic disease: Applications and trends.Frontiers in cardiovascular medicine · 2022
   Review
4. A case series of myocardial infarction in SARS-CoV-2-infected patients: Same complication, different outcomes.Clinical case reports · 2022
   Article
5. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID).International journal of cardiology · 2021
   Article
6. Surviving to Acute Myocardial Infarction: The Role of Psychological Factors and Alexithymia in Delayed Time to Searching Care: A Systematic Review.Journal of clinical medicine · 2021
   Review
7. Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemic.ESC heart failure · 2021
   Observational
8. [Quality indicators and structural requirements for Cardiac Arrest Centers-Update 2021].Notfall & rettungsmedizin · 2021
   Review
9. Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.Anatolian journal of cardiology · 2020
   Observational
10. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.European heart journal · 2020
    Observational
11. Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction.European heart journal. Acute cardiovascular care · 2020
    Article
12. Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury.JACC. Basic to translational science · 2019
    Review
13. [Why do we need cardiac arrest centers?]Herz · 2018
    Article

Corrections and comments

• Comment on
  Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as